Skip to main content

Cannabinoid receptor-1 inhibition causes anesthetic-induced excitation in septic rats

Introduction

In systemic inflammation and sepsis, the endo-cannabinoid system is upregulated [1]. While it is known that neuronal cannabinoid signalling via cannabinoid receptor-1 (CB1) in the central nervous system represents an intrinsic neuroprotective response [2] and exerts anti-epileptic activity [3], inhibition of CB1 (CB1inh) has been suggested as an experimental target for sepsis therapy [4]. We studied the effects of CB1inh in rats with experimental sepsis during anesthesia induction with pentobarbital.

Methods

Five groups of Lewis rats were included in the study: Group 1 - sham-operated controls treated with CB1inh (AM281, 2.5 mg/kg i.v., n = 12), Group 2 - animals with colon ascendens stent peritonitis (CASP)-induced sepsis treated with CB1inh (n = 12). As additional control groups we administered in CASP animals the CB1 agonist ACEA (2.5 mg/kg i.v.; Group 3; n = 4) or the solvent DMSO (Group 4; n = 4). In Group 5 we administered 50 mg/kg ketamine for induction of anesthesia 14 hours following the CASP treated by CB1inh. All other groups received a standard dose of pentobarbital (40 mg/kg i.v.) 14 hours following CASP procedure.

Results

In five out of 12 septic animals (42%) with CB1inh (Group 2) we observed tonic-clonic seizures immediately after induction of anesthesia with a standard dose of pentobarbital. In sham-operated animals (Group 1) or CASP animals without CB1inh (Group 4) we did not observe anesthetic-induced excitation. Replacement of the barbiturate by ketamine (Group 5) avoided seizures as well as treatment with the CB1 agonist (Group 3).

Conclusions

CB1 inhibition in sepsis may increase the incidence of anesthetic-induced excitation and reduce CB1-mediated intrinsic neuroprotective response.

References

  1. 1.

    Varga K, et al.: FASEB J. 1998, 12: 1035-1044.

    CAS  PubMed  Google Scholar 

  2. 2.

    Hwang , et al.: Life Sci. 2010, 86: 615-623.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  3. 3.

    Pacher , et al.: Pharmacol Rev. 2006, 58: 389-462.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  4. 4.

    Kadoi , et al.: Br J Anaesth. 2005, 94: 563-568.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to R Kuschnereit.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Kuschnereit, R., Lehmann, C., Whynot, S. et al. Cannabinoid receptor-1 inhibition causes anesthetic-induced excitation in septic rats. Crit Care 15, P360 (2011). https://doi.org/10.1186/cc9780

Download citation

Keywords

  • Ketamine
  • Pentobarbital
  • AM281
  • Septic Animal
  • Experimental Sepsis